LINC00184: A Potential Drug Target and Biomarker (G100302691)

Target Name: LINC00184

NCBI ID: G100302691

LINC00184

Other Name(s): Long intergenic non-protein coding RNA 184 | HANC | NCRNA00184 | long intergenic non-protein coding RNA 184

LINC00184: A Potential Drug Target and Biomarker

LINC00184 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the potential drug targeting of LINC00184 and its potential as a biomarker for these diseases.

Potential Drug Target

LINC00184 is a small non-coding RNA molecule that is expressed in a variety of tissues and cells. It is a key regulator of cell adhesion and has been shown to play a role in the development and progression of a variety of diseases. One of the most promising aspects of LINC00184 as a drug target is its ability to modulate the expression of other genes, including those involved in cancer progression and neurodegenerative diseases.

Studies have shown that LINC00184 can inhibit the activity of the transcription factor, NF-kappa-B, which is involved in the regulation of cancer growth and progression. Additionally, LINC00184 has been shown to downregulate the expression of the oncogene, PDGFRA, which is involved in the development of neurodegenerative diseases. These findings suggest that LINC00184 may be an effective target for the treatment of these diseases.

Potential Biomarker

In addition to its potential as a drug target, LINC00184 may also be a useful biomarker for the diagnosis and progression of various diseases. Its regulation of cell adhesion makes it an attractive candidate for the study of tissue-specific markers, such as those used in the diagnosis of cancer. Additionally, LINC00184 has been shown to be expressed in a variety of tissues and cells, including those involved in neurodegenerative diseases, making it a potential biomarker for these conditions as well.

In conclusion, LINC00184 is a promising drug target and biomarker that has the potential to revolutionize our understanding of a variety of diseases. Further research is needed to fully understand its mechanisms of action and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 184

The "LINC00184 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00184 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets